| Muscle targeting complexes and uses thereof for treating facioscapulohumeral … |
2023-3-16 |
2023-6-29 |
|
| Anti-transferrin receptor antibody and uses thereof |
2023-3-10 |
2023-8-17 |
|
| Muscle targeting complexes and uses thereof for treating dystrophinopathies |
2023-3-10 |
2023-8-31 |
|
| Muscle targeting complexes and uses thereof for treating facioscapulohumeral … |
2022-12-09 |
2023-4-20 |
|
| Muscle targeting complexes for treating facioscapulohumeral muscular dystrophy |
2022-11-10 |
2023-5-19 |
|
| Muscle targeting complexes for treating dystrophinopathies |
2022-10-31 |
2023-5-04 |
|
| Dosing of muscle targeting complexes for treating dystrophinopathies |
2022-9-15 |
2023-3-23 |
|
| Anti-transferrin receptor (tfr) antibody and uses thereof |
2022-7-24 |
2022-9-01 |
|
| Muscle targeting complexes and uses thereof for treating dystrophinopathies |
2022-7-08 |
2023-1-12 |
|
| Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
2022-7-08 |
2023-1-12 |
|
| Muscle targeting complexes and uses thereof for treating dystrophinopathies |
2022-7-08 |
2023-2-09 |
|
| Muscle targeting complexes and formulations thereof for treating … |
2022-7-08 |
2023-1-12 |
|
| Muscle targeting complexes and formulations for treating dystrophinopathies |
2022-7-08 |
2023-1-12 |
|
| Muscle targeting complexes and uses thereof for treating dystrophinopathies |
2022-7-08 |
2023-3-02 |
|
| Muscle targeting complexes and uses thereof for modulation of genes associated … |
2022-7-08 |
2023-6-29 |
|
| Muscle targeting complexes and uses thereof for treating dystrophinopathies |
2022-7-08 |
2023-1-12 |
|
| Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
2022-7-08 |
2023-4-25 |
2023-4-25 |
| Muscle targeting complexes and uses thereof for treating dystrophinopathies |
2022-7-08 |
2023-2-16 |
|
| Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
2022-7-03 |
2022-9-01 |
|
| Muscle targeting complexes and uses thereof for treating facioscapulohumeral … |
2022-7-03 |
2022-9-01 |
|
| Muscle targeting complexes and uses thereof for treating dystrophinopathies |
2022-7-03 |
2022-9-01 |
|
| Muscle targeting complexes and uses thereof for modulation of genes associated … |
2022-7-01 |
2023-3-16 |
|
| Muscle targeting complexes and uses thereof for treating friedreich's ataxia |
2022-6-17 |
2022-12-29 |
|
| Muscle targeting complexes and uses thereof for treating pompe disease |
2022-6-17 |
2022-12-29 |
|
| Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
2021-12-30 |
2022-7-07 |
|
| Muscle targeting complexes and uses thereof for treating facioscapulohumeral … |
2021-12-30 |
2023-8-01 |
|
| Antibody-oligonucleotide complexes and uses thereof |
2021-12-03 |
2022-6-09 |
|
| Antibody-oligonucleotide complexes and uses thereof |
2021-12-03 |
2023-9-12 |
|
| Muscle targeting complexes and uses thereof for treating dystrophinopathies |
2021-10-14 |
2022-1-27 |
|
| Method for preparing protein-oligonucleotide complex |
2021-9-03 |
2023-7-18 |
|
| Methods of preparing protein-oligonucleotide complexes |
2021-9-03 |
2023-7-12 |
|
| Muscle targeting complexes and uses thereof for treating dystrophinopathies |
2021-7-09 |
2022-1-27 |
|
| Muscle-targeting complexes and uses thereof in treating muscle atrophy |
2021-7-09 |
2022-1-27 |
|
| Muscle-targeting complexes and their uses |
2021-7-09 |
2023-8-15 |
|
| Anti-transferrin receptor (TFR) antibodies and uses thereof |
2021-7-09 |
2023-3-24 |
|
| Muscle targeting complexes and their use for the treatment of facial scapula … |
2021-7-09 |
2023-4-05 |
|
| Muscle-targeted complexes and their use for treating myotonic dystrophy |
2021-7-09 |
2023-8-15 |
|
| Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
2021-3-18 |
2021-7-22 |
|
| Muscle-targeting complexes and uses thereof |
2021-3-18 |
2021-7-29 |
|
| Muscle targeting complexes and uses thereof for treating fibrodysplasia … |
2021-1-31 |
2021-3-25 |
|
| Muscle targeting complexes and uses thereof for treating friedreich's ataxia |
2021-1-31 |
2021-3-25 |
|
| Muscle-targeting complexes and uses thereof in treating muscle atrophy |
2021-1-31 |
2021-3-01 |
|
| Muscle targeting complexes and uses thereof for treating pompe disease |
2021-1-28 |
2021-3-01 |
|
| Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
2021-1-26 |
2021-3-25 |
|
| Anti-transferrin receptor (tfr) antibody and uses thereof |
2021-1-08 |
2023-4-06 |
|
| Muscle targeting complexes and uses thereof for modulation of genes associated … |
2021-1-08 |
2021-7-15 |
|
| Its use for the modulation of muscle targeting complexes and genes associated … |
2021-1-08 |
2023-3-27 |
|
| Muscle targeting complexes and uses thereof for modulation of acvr1 |
2021-1-08 |
2021-7-15 |
|
| Muscle-targeting complexes and their uses |
2021-1-08 |
2023-3-13 |
|
| Muscle targeting complexes and uses thereof for treating dystrophinopathies |
2021-1-08 |
2021-7-15 |
|
| Muscle-targeting complexes and uses thereof in treating muscle atrophy |
2021-1-08 |
2021-7-29 |
|
| Muscle targeting complexes and uses thereof for modulation of milck1 |
2021-1-08 |
2022-5-12 |
|
| Muscle targeting complexes and uses thereof for modulation of genes associated … |
2021-1-08 |
2021-7-15 |
|
| Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
2020-10-16 |
2021-4-22 |
|
| Methods of preparing protein-oligonucleotide complexes |
2020-6-05 |
2022-4-13 |
|
| Muscle targeting complexes and uses thereof for treating hypertrophic … |
2019-8-02 |
2021-10-21 |
|
| Muscle targeting complexes and uses thereof for treating centronuclear myopathy |
2019-8-02 |
2021-10-21 |
|
| 抗体-寡核苷酸复合物及其用途 |
2021-12-03 |
2023-9-12 |
|